Search | VHL Search Portal

1.

Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.

Wei, John T; Barocas, Daniel; Carlsson, Sigrid; Coakley, Fergus; Eggener, Scott; Etzioni, Ruth; Fine, Samson W; Han, Misop; Kim, Sennett K; Kirkby, Erin; Konety, Badrinath R; Miner, Martin; Moses, Kelvin; Nissenberg, Merel G; Pinto, Peter A; Salami, Simpa S; Souter, Lesley; Thompson, Ian M; Lin, Daniel W.

J Urol ; 210(1): 54-63, 2023 07.

Article in English | MEDLINE | ID: mdl-37096575

2.

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.

Wei, John T; Barocas, Daniel; Carlsson, Sigrid; Coakley, Fergus; Eggener, Scott; Etzioni, Ruth; Fine, Samson W; Han, Misop; Kim, Sennett K; Kirkby, Erin; Konety, Badrinath R; Miner, Martin; Moses, Kelvin; Nissenberg, Merel G; Pinto, Peter A; Salami, Simpa S; Souter, Lesley; Thompson, Ian M; Lin, Daniel W.

J Urol ; 210(1): 46-53, 2023 07.

Article in English | MEDLINE | ID: mdl-37096582

3.

Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.

Singhal, Udit; Hollenbeck, Brent K; Kaffenberger, Samuel D; Salami, Simpa S; George, Arvin K; Skolarus, Ted A; Montgomery, Jeffrey S; Wittmann, Daniela A; Miller, David C; Wei, John T; Palapattu, Ganesh S; Montie, James E; Dunn, Rodney L; Morgan, Todd M.

J Urol ; 210(5): 771-777, 2023 Nov.

Article in English | MEDLINE | ID: mdl-37566643

4.

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.

Moses, Kelvin A; Sprenkle, Preston C; Bahler, Clinton; Box, Geoffrey; Carlsson, Sigrid V; Catalona, William J; Dahl, Douglas M; Dall'Era, Marc; Davis, John W; Drake, Bettina F; Epstein, Jonathan I; Etzioni, Ruth B; Farrington, Thomas A; Garraway, Isla P; Jarrard, David; Kauffman, Eric; Kaye, Deborah; Kibel, Adam S; LaGrange, Chad A; Maroni, Paul; Ponsky, Lee; Reys, Brian; Salami, Simpa S; Sanchez, Alejandro; Seibert, Tyler M; Shaneyfelt, Terrence M; Smaldone, Marc C; Sonn, Geoffrey; Tyson, Mark D; Vapiwala, Neha; Wake, Robert; Washington, Samuel; Yu, Alice; Yuh, Bertram; Berardi, Ryan A; Freedman-Cass, Deborah A.

J Natl Compr Canc Netw ; 21(3): 236-246, 2023 03.

Article in English | MEDLINE | ID: mdl-36898362

5.

Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.

Tosoian, Jeffrey J; Trock, Bruce J; Morgan, Todd M; Salami, Simpa S; Tomlins, Scott A; Spratt, Daniel E; Siddiqui, Javed; Kunju, Lakshmi P; Botbyl, Rachel; Chopra, Zoey; Pandian, Balaji; Eyrich, Nicholas W; Longton, Gary; Zheng, Yingye; Palapattu, Ganesh S; Wei, John T; Niknafs, Yashar S; Chinnaiyan, Arul M.

J Urol ; 205(3): 732-739, 2021 03.

Article in English | MEDLINE | ID: mdl-33080150

6.

Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.

Miyahira, Andrea K; Den, Robert B; Carlo, Maria I; de Leeuw, Renée; Hope, Thomas A; Karzai, Fatima; McKay, Rana R; Salami, Simpa S; Simons, Jonathan W; Pienta, Kenneth J; Soule, Howard R.

Prostate ; 79(3): 244-258, 2019 02.

Article in English | MEDLINE | ID: mdl-30381857

7.

Bringing Prostate Cancer Germline Genetics into Clinical Practice.

Das, Sanjay; Salami, Simpa S; Spratt, Daniel E; Kaffenberger, Samuel D; Jacobs, Michelle F; Morgan, Todd M.

J Urol ; 202(2): 223-230, 2019 08.

Article in English | MEDLINE | ID: mdl-30730411

8.

International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.

Berlin, Alejandro; Moraes, Fabio Y; Sanmamed, Noelia; Glicksman, Rachel; Koven, Alexander; Espin-Garcia, Osvaldo; Leite, Elton T T; Silva, João L F; Gadia, Rafael; Nesbitt, Michael; Catton, Charles N; Kaffenberger, Samuel; Salami, Simpa S; Morgan, Todd M; Hearn, Jason W D; Jackson, Will C; Mehra, Rohit; Chung, Peter; Fleshner, Neil E; Zumsteg, Zachary S; Dess, Robert T; Feng, Felix Y; Finelli, Antonio; Spratt, Daniel E.

J Urol ; 201(2): 284-291, 2019 02.

Article in English | MEDLINE | ID: mdl-30153435

9.

Editorial Comment.

Singhal, Udit; Salami, Simpa S.

J Urol ; 210(2): 270-271, 2023 Aug.

Article in English | MEDLINE | ID: mdl-37232092

10.

The genomics of renal cell carcinoma and its role in renal mass biopsy.

Salami, Simpa S; George, Arvin K; Udager, Aaron M.

Curr Opin Urol ; 28(4): 383-391, 2018 07.

Article in English | MEDLINE | ID: mdl-29708949

11.

Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.

Salami, Simpa S; Ben-Levi, Eran; Yaskiv, Oksana; Turkbey, Baris; Villani, Robert; Rastinehad, Ardeshir R.

J Magn Reson Imaging ; 45(2): 610-616, 2017 02.

Article in English | MEDLINE | ID: mdl-27405584

12.

Active surveillance for incidental renal mass in the octogenarian.

Celtik, Kenan E; Shah, Paras H; Patel, Vinay R; Moreira, Daniel M; George, Arvin K; Iacovelli, Valerio; Alom, Manaf; Ng, Andrew; Herati, Amin; Salami, Simpa S; Bierwiler, Hannah; Schwartz, Michael J; Richstone, Lee; Steckel, Joph; Vira, Manish A; Kavoussi, Louis R.

World J Urol ; 35(7): 1089-1094, 2017 Jul.

Article in English | MEDLINE | ID: mdl-27803967

13.

Outcomes of Laparoscopic Partial Nephrectomy in Patients Continuing Aspirin Therapy.

Leavitt, David A; Keheila, Mohamed; Siev, Michael; Shah, Paras H; Moreira, Daniel M; George, Arvin K; Salami, Simpa S; Schwartz, Michael J; Richstone, Lee; Vira, Manish A; Kavoussi, Louis R.

J Urol ; 195(4 Pt 1): 859-64, 2016 Apr.

Article in English | MEDLINE | ID: mdl-26521717

14.

In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?

Salami, Simpa S; Ben-Levi, Eran; Yaskiv, Oksana; Ryniker, Laura; Turkbey, Baris; Kavoussi, Louis R; Villani, Robert; Rastinehad, Ardeshir R.

BJU Int ; 115(4): 562-70, 2015 Apr.

Article in English | MEDLINE | ID: mdl-25252133

15.

Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.

Salami, Simpa S; Vira, Manish A; Turkbey, Baris; Fakhoury, Mathew; Yaskiv, Oksana; Villani, Robert; Ben-Levi, Eran; Rastinehad, Ardeshir R.

Cancer ; 120(18): 2876-82, 2014 Sep 15.

Article in English | MEDLINE | ID: mdl-24917122

16.

Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy.

Rastinehad, Ardeshir R; Turkbey, Baris; Salami, Simpa S; Yaskiv, Oksana; George, Arvin K; Fakhoury, Mathew; Beecher, Karin; Vira, Manish A; Kavoussi, Louis R; Siegel, David N; Villani, Robert; Ben-Levi, Eran.

J Urol ; 191(6): 1749-54, 2014 Jun.

Article in English | MEDLINE | ID: mdl-24333515

17.

Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.

Tosoian, Jeffrey J; Zhang, Yuping; Xiao, Lanbo; Xie, Cassie; Samora, Nathan L; Niknafs, Yashar S; Chopra, Zoey; Siddiqui, Javed; Zheng, Heng; Herron, Grace; Vaishampayan, Neil; Robinson, Hunter S; Arivoli, Kumaran; Trock, Bruce J; Ross, Ashley E; Morgan, Todd M; Palapattu, Ganesh S; Salami, Simpa S; Kunju, Lakshmi P; Tomlins, Scott A; Sokoll, Lori J; Chan, Daniel W; Srivastava, Sudhir; Feng, Ziding; Sanda, Martin G; Zheng, Yingye; Wei, John T; Chinnaiyan, Arul M.

JAMA Oncol ; 2024 Apr 18.

Article in English | MEDLINE | ID: mdl-38635241

18.

Diagnostic accuracy of the PROMIS study.

Salami, Simpa S; George, Arvin K; Montgomery, Jeffrey S; Morgan, Todd M; Palapattu, Ganesh S.

Lancet ; 390(10092): 362, 2017 07 22.

Article in English | MEDLINE | ID: mdl-28745602

19.

Editorial Comment.

Salami, Simpa S.

J Urol ; 199(1): 104, 2018 01.

Article in English | MEDLINE | ID: mdl-29031674

20.

Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer.

Cani, Andi K; Salami, Simpa S.

Cancer J ; 29(4): 220-225, 2023.

Article in English | MEDLINE | ID: mdl-37471612

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.

Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.

Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.

Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy Meeting.

Bringing Prostate Cancer Germline Genetics into Clinical Practice.

International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.

Editorial Comment.

The genomics of renal cell carcinoma and its role in renal mass biopsy.

Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.

Active surveillance for incidental renal mass in the octogenarian.

Outcomes of Laparoscopic Partial Nephrectomy in Patients Continuing Aspirin Therapy.

In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?

Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.

Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy.

Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.

Diagnostic accuracy of the PROMIS study.

Editorial Comment.

Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer.